These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 8529657)
1. Transcriptional activation and repression, two properties of the lymphoid-specific transcription factor Oct-2a. Friedl EM; Matthias P Eur J Biochem; 1995 Nov; 234(1):308-16. PubMed ID: 8529657 [TBL] [Abstract][Full Text] [Related]
2. Mapping of the transcriptional repression domain of the lymphoid-specific transcription factor oct-2A. Friedl EM; Matthias P J Biol Chem; 1996 Jun; 271(24):13927-30. PubMed ID: 8663230 [TBL] [Abstract][Full Text] [Related]
3. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells. Müller-Immerglück MM; Schaffner W; Matthias P EMBO J; 1990 May; 9(5):1625-34. PubMed ID: 2328728 [TBL] [Abstract][Full Text] [Related]
4. Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. Seipel K; Georgiev O; Schaffner W EMBO J; 1992 Dec; 11(13):4961-8. PubMed ID: 1464321 [TBL] [Abstract][Full Text] [Related]
5. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375 [TBL] [Abstract][Full Text] [Related]
6. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription. Tanaka M; Clouston WM; Herr W Mol Cell Biol; 1994 Sep; 14(9):6046-55. PubMed ID: 8065338 [TBL] [Abstract][Full Text] [Related]
7. Both Oct-1 and Oct-2A contain domains which can activate the ubiquitously expressed U2 snRNA genes. Yang J; Müller-Immerglück MM; Seipel K; Janson L; Westin G; Schaffner W; Pettersson U EMBO J; 1991 Aug; 10(8):2291-6. PubMed ID: 1829677 [TBL] [Abstract][Full Text] [Related]
8. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Tanaka M; Herr W Cell; 1990 Feb; 60(3):375-86. PubMed ID: 2302733 [TBL] [Abstract][Full Text] [Related]
9. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. Ambrosetti DC; Schöler HR; Dailey L; Basilico C J Biol Chem; 2000 Jul; 275(30):23387-97. PubMed ID: 10801796 [TBL] [Abstract][Full Text] [Related]
10. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Schreiber E; Harshman K; Kemler I; Malipiero U; Schaffner W; Fontana A Nucleic Acids Res; 1990 Sep; 18(18):5495-503. PubMed ID: 2216722 [TBL] [Abstract][Full Text] [Related]
11. C-terminal domain (CTD) of RNA-polymerase II and N-terminal segment of the human TATA binding protein (TBP) can mediate remote and proximal transcriptional activation, respectively. Seipel K; Georgiev O; Gerber HP; Schaffner W Nucleic Acids Res; 1993 Dec; 21(24):5609-15. PubMed ID: 8284205 [TBL] [Abstract][Full Text] [Related]
12. The C-terminus of the B cell activator Oct-2 functions as an activation domain in yeast. Mead J; Elliston K; Mark DF; Ludmerer SW Biochem Biophys Res Commun; 1994 Dec; 205(3):1998-2007. PubMed ID: 7811293 [TBL] [Abstract][Full Text] [Related]
13. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. Abdulkadir SA; Krishna S; Thanos D; Maniatis T; Strominger JL; Ono SJ J Exp Med; 1995 Aug; 182(2):487-500. PubMed ID: 7629508 [TBL] [Abstract][Full Text] [Related]
14. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains. Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775 [TBL] [Abstract][Full Text] [Related]
15. Differential in vivo activation of the class II and class III snRNA genes by the POU-specific domain of Oct-1. Murphy S Nucleic Acids Res; 1997 Jun; 25(11):2068-76. PubMed ID: 9153304 [TBL] [Abstract][Full Text] [Related]
16. Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1. Shore P; Dietrich W; Corcoran LM Nucleic Acids Res; 2002 Apr; 30(8):1767-73. PubMed ID: 11937630 [TBL] [Abstract][Full Text] [Related]
17. Reconstitution of transcriptional activation domains by reiteration of short peptide segments reveals the modular organization of a glutamine-rich activation domain. Tanaka M; Herr W Mol Cell Biol; 1994 Sep; 14(9):6056-67. PubMed ID: 8065339 [TBL] [Abstract][Full Text] [Related]
18. A B-cell coactivator of octamer-binding transcription factors. Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176 [TBL] [Abstract][Full Text] [Related]
19. Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements. Tanaka M; Grossniklaus U; Herr W; Hernandez N Genes Dev; 1988 Dec; 2(12B):1764-78. PubMed ID: 2853685 [TBL] [Abstract][Full Text] [Related]
20. Transactivation of the human papilloma virus 16 octamer motif by the octamer binding protein Oct-2 requires both the N and C terminal activation domains. Morris PJ; Ring CJ; Lillycrop KA; Latchman DS Nucleic Acids Res; 1993 Sep; 21(19):4506-10. PubMed ID: 8233784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]